Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
2.080
-0.030 (-1.42%)
At close: Sep 4, 2026, 4:00 PM EDT
2.082
+0.002 (0.09%)
After-hours: Sep 4, 2026, 5:40 PM EDT
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $191.23 million as of September 4, 2026. Its market cap has decreased by -4.28% in one year.
Market Cap
191.23M
Enterprise Value
177.59M
1-Year Change
-4.28%
Ranking
Category
Stock Price
$2.08
ChartMarket Cap Chart
Since October 18, 2019, Innate Pharma's market cap has decreased from $480.08M to $191.23M, a decrease of -60.17%. That is a compound annual growth rate of -12.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 191.23M | 10.29% |
| Dec 31, 2025 | 173.38M | 4.71% |
| Dec 31, 2024 | 165.58M | -29.08% |
| Dec 29, 2023 | 233.49M | -17.19% |
| Dec 30, 2022 | 281.97M | -29.50% |
| Dec 31, 2021 | 399.94M | 19.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NovaBridge Biosciences | 208.80M |
| Voyager Therapeutics | 208.27M |
| Armata Pharmaceuticals | 205.24M |
| Oramed Pharmaceuticals | 205.07M |
| Precision BioSciences | 203.42M |
| Cue Biopharma | 201.01M |
| Alpha Cognition | 200.57M |
| Nkarta | 199.83M |